Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, Global Outlook and Forecast 2022-2028
SGLT2 is a member of the sodium-glucose cotransporter family which are sodium-dependent glucose transport proteins. SGLT2 is the major cotransporter involved in glucose reabsorption in the kidney.The growing global type-2 diabetes population promotes the growth of SGLT2 drugs.
This report contains market size and forecasts of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors in global, including the following market information:
Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors companies in 2021 (%)
The global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Invokana (Canagliflozin) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors include Eli Lilly, Janssen Pharmaceuticals, Astellas, Boehringer Ingelheim, AstraZeneca, Bristol Myers Squibb and Kotobuki Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segment Percentages, by Type, 2021 (%)
Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segment Percentages, by Application, 2021 (%)
Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors revenues share in global market, 2021 (%)
Key companies Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors in global, including the following market information:
Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors companies in 2021 (%)
The global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Invokana (Canagliflozin) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors include Eli Lilly, Janssen Pharmaceuticals, Astellas, Boehringer Ingelheim, AstraZeneca, Bristol Myers Squibb and Kotobuki Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segment Percentages, by Type, 2021 (%)
- Invokana (Canagliflozin)
- Jardiance (Empagliflozin)
- Farxiga/Forxiga (Dapagliflozin)
- Suglat (Ipragliflozin)
Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Medical Research Institute
- Other
Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors revenues share in global market, 2021 (%)
Key companies Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Eli Lilly
- Janssen Pharmaceuticals
- Astellas
- Boehringer Ingelheim
- AstraZeneca
- Bristol Myers Squibb
- Kotobuki Pharmaceutical
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS OVERALL MARKET SIZE
2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size: 2021 VS 2028
2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Players in Global Market
3.2 Top Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Companies Ranked by Revenue
3.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Companies
3.4 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Companies
3.5 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Type
3.8 Tier 1, Tier 2 and Tier 3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Players in Global Market
3.8.1 List of Global Tier 1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Companies
3.8.2 List of Global Tier 2 and Tier 3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Markets, 2021 & 2028
4.1.2 Invokana (Canagliflozin)
4.1.3 Jardiance (Empagliflozin)
4.1.4 Farxiga/Forxiga (Dapagliflozin)
4.1.5 Suglat (Ipragliflozin)
4.2 By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue & Forecasts
4.2.1 By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, 2017-2022
4.2.2 By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, 2023-2028
4.2.3 By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share, 2017-2028
4.3 By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales & Forecasts
4.3.1 By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, 2017-2022
4.3.2 By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, 2023-2028
4.3.3 By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share, 2017-2028
4.4 By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Medical Research Institute
5.1.4 Other
5.2 By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue & Forecasts
5.2.1 By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, 2017-2022
5.2.2 By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, 2023-2028
5.2.3 By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share, 2017-2028
5.3 By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales & Forecasts
5.3.1 By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, 2017-2022
5.3.2 By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, 2023-2028
5.3.3 By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share, 2017-2028
5.4 By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2021 & 2028
6.2 By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue & Forecasts
6.2.1 By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, 2017-2022
6.2.2 By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, 2023-2028
6.2.3 By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share, 2017-2028
6.3 By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales & Forecasts
6.3.1 By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, 2017-2022
6.3.2 By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, 2023-2028
6.3.3 By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, 2017-2028
6.4.2 By Country - North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, 2017-2028
6.4.3 US Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.4.4 Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.4.5 Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, 2017-2028
6.5.2 By Country - Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, 2017-2028
6.5.3 Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.5.4 France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.5.5 U.K. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.5.6 Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.5.7 Russia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.5.8 Nordic Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.5.9 Benelux Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, 2017-2028
6.6.2 By Region - Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, 2017-2028
6.6.3 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.6.4 Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.6.5 South Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.6.6 Southeast Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.6.7 India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, 2017-2028
6.7.2 By Country - South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, 2017-2028
6.7.3 Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.7.4 Argentina Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, 2017-2028
6.8.3 Turkey Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.8.4 Israel Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.8.5 Saudi Arabia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.8.6 UAE Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Eli Lilly
7.1.1 Eli Lilly Corporate Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Major Product Offerings
7.1.4 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Revenue in Global (2017-2022)
7.1.5 Eli Lilly Key News
7.2 Janssen Pharmaceuticals
7.2.1 Janssen Pharmaceuticals Corporate Summary
7.2.2 Janssen Pharmaceuticals Business Overview
7.2.3 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Major Product Offerings
7.2.4 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Revenue in Global (2017-2022)
7.2.5 Janssen Pharmaceuticals Key News
7.3 Astellas
7.3.1 Astellas Corporate Summary
7.3.2 Astellas Business Overview
7.3.3 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Major Product Offerings
7.3.4 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Revenue in Global (2017-2022)
7.3.5 Astellas Key News
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Corporate Summary
7.4.2 Boehringer Ingelheim Business Overview
7.4.3 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Major Product Offerings
7.4.4 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Revenue in Global (2017-2022)
7.4.5 Boehringer Ingelheim Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Major Product Offerings
7.5.4 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Revenue in Global (2017-2022)
7.5.5 AstraZeneca Key News
7.6 Bristol Myers Squibb
7.6.1 Bristol Myers Squibb Corporate Summary
7.6.2 Bristol Myers Squibb Business Overview
7.6.3 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Major Product Offerings
7.6.4 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Revenue in Global (2017-2022)
7.6.5 Bristol Myers Squibb Key News
7.7 Kotobuki Pharmaceutical
7.7.1 Kotobuki Pharmaceutical Corporate Summary
7.7.2 Kotobuki Pharmaceutical Business Overview
7.7.3 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Major Product Offerings
7.7.4 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Revenue in Global (2017-2022)
7.7.5 Kotobuki Pharmaceutical Key News
8 GLOBAL SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Capacity, 2017-2028
8.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Capacity of Key Manufacturers in Global Market
8.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS SUPPLY CHAIN ANALYSIS
10.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Value Chain
10.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Upstream Market
10.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS OVERALL MARKET SIZE
2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size: 2021 VS 2028
2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Players in Global Market
3.2 Top Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Companies Ranked by Revenue
3.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Companies
3.4 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Companies
3.5 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Type
3.8 Tier 1, Tier 2 and Tier 3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Players in Global Market
3.8.1 List of Global Tier 1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Companies
3.8.2 List of Global Tier 2 and Tier 3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Markets, 2021 & 2028
4.1.2 Invokana (Canagliflozin)
4.1.3 Jardiance (Empagliflozin)
4.1.4 Farxiga/Forxiga (Dapagliflozin)
4.1.5 Suglat (Ipragliflozin)
4.2 By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue & Forecasts
4.2.1 By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, 2017-2022
4.2.2 By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, 2023-2028
4.2.3 By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share, 2017-2028
4.3 By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales & Forecasts
4.3.1 By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, 2017-2022
4.3.2 By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, 2023-2028
4.3.3 By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share, 2017-2028
4.4 By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Medical Research Institute
5.1.4 Other
5.2 By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue & Forecasts
5.2.1 By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, 2017-2022
5.2.2 By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, 2023-2028
5.2.3 By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share, 2017-2028
5.3 By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales & Forecasts
5.3.1 By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, 2017-2022
5.3.2 By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, 2023-2028
5.3.3 By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share, 2017-2028
5.4 By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2021 & 2028
6.2 By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue & Forecasts
6.2.1 By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, 2017-2022
6.2.2 By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, 2023-2028
6.2.3 By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share, 2017-2028
6.3 By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales & Forecasts
6.3.1 By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, 2017-2022
6.3.2 By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, 2023-2028
6.3.3 By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, 2017-2028
6.4.2 By Country - North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, 2017-2028
6.4.3 US Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.4.4 Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.4.5 Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, 2017-2028
6.5.2 By Country - Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, 2017-2028
6.5.3 Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.5.4 France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.5.5 U.K. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.5.6 Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.5.7 Russia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.5.8 Nordic Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.5.9 Benelux Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, 2017-2028
6.6.2 By Region - Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, 2017-2028
6.6.3 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.6.4 Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.6.5 South Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.6.6 Southeast Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.6.7 India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, 2017-2028
6.7.2 By Country - South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, 2017-2028
6.7.3 Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.7.4 Argentina Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, 2017-2028
6.8.3 Turkey Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.8.4 Israel Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.8.5 Saudi Arabia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
6.8.6 UAE Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Eli Lilly
7.1.1 Eli Lilly Corporate Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Major Product Offerings
7.1.4 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Revenue in Global (2017-2022)
7.1.5 Eli Lilly Key News
7.2 Janssen Pharmaceuticals
7.2.1 Janssen Pharmaceuticals Corporate Summary
7.2.2 Janssen Pharmaceuticals Business Overview
7.2.3 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Major Product Offerings
7.2.4 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Revenue in Global (2017-2022)
7.2.5 Janssen Pharmaceuticals Key News
7.3 Astellas
7.3.1 Astellas Corporate Summary
7.3.2 Astellas Business Overview
7.3.3 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Major Product Offerings
7.3.4 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Revenue in Global (2017-2022)
7.3.5 Astellas Key News
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Corporate Summary
7.4.2 Boehringer Ingelheim Business Overview
7.4.3 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Major Product Offerings
7.4.4 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Revenue in Global (2017-2022)
7.4.5 Boehringer Ingelheim Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Major Product Offerings
7.5.4 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Revenue in Global (2017-2022)
7.5.5 AstraZeneca Key News
7.6 Bristol Myers Squibb
7.6.1 Bristol Myers Squibb Corporate Summary
7.6.2 Bristol Myers Squibb Business Overview
7.6.3 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Major Product Offerings
7.6.4 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Revenue in Global (2017-2022)
7.6.5 Bristol Myers Squibb Key News
7.7 Kotobuki Pharmaceutical
7.7.1 Kotobuki Pharmaceutical Corporate Summary
7.7.2 Kotobuki Pharmaceutical Business Overview
7.7.3 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Major Product Offerings
7.7.4 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Revenue in Global (2017-2022)
7.7.5 Kotobuki Pharmaceutical Key News
8 GLOBAL SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Capacity, 2017-2028
8.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Capacity of Key Manufacturers in Global Market
8.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS SUPPLY CHAIN ANALYSIS
10.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Value Chain
10.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Upstream Market
10.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors in Global Market
Table 2. Top Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Companies, 2017-2022
Table 5. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Companies, (Kg), 2017-2022
Table 6. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price (2017-2022) & (USD/Kg)
Table 8. Global Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Type
Table 9. List of Global Tier 1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), 2017-2022
Table 15. By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), 2023-2028
Table 16. By Application – Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), 2017-2022
Table 20. By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), 2023-2028
Table 21. By Region – Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), 2017-2022
Table 25. By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), 2023-2028
Table 26. By Country - North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, (Kg), 2017-2022
Table 29. By Country - North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, (Kg), 2023-2028
Table 30. By Country - Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, (Kg), 2017-2022
Table 33. By Country - Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, (Kg), 2023-2028
Table 34. By Region - Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, (Kg), 2017-2022
Table 37. By Region - Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, (Kg), 2023-2028
Table 38. By Country - South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, (Kg), 2017-2022
Table 41. By Country - South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, (Kg), 2023-2028
Table 46. Eli Lilly Corporate Summary
Table 47. Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offerings
Table 48. Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 49. Janssen Pharmaceuticals Corporate Summary
Table 50. Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offerings
Table 51. Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 52. Astellas Corporate Summary
Table 53. Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offerings
Table 54. Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 55. Boehringer Ingelheim Corporate Summary
Table 56. Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offerings
Table 57. Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 58. AstraZeneca Corporate Summary
Table 59. AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offerings
Table 60. AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 61. Bristol Myers Squibb Corporate Summary
Table 62. Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offerings
Table 63. Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 64. Kotobuki Pharmaceutical Corporate Summary
Table 65. Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offerings
Table 66. Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 67. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 68. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Capacity Market Share of Key Manufacturers, 2020-2022
Table 69. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production by Region, 2017-2022 (Kg)
Table 70. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production by Region, 2023-2028 (Kg)
Table 71. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Opportunities & Trends in Global Market
Table 72. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Drivers in Global Market
Table 73. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Restraints in Global Market
Table 74. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Raw Materials
Table 75. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Raw Materials Suppliers in Global Market
Table 76. Typical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Downstream
Table 77. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Downstream Clients in Global Market
Table 78. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Distributors and Sales Agents in Global Market
Table 1. Key Players of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors in Global Market
Table 2. Top Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Companies, 2017-2022
Table 5. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Companies, (Kg), 2017-2022
Table 6. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price (2017-2022) & (USD/Kg)
Table 8. Global Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Type
Table 9. List of Global Tier 1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), 2017-2022
Table 15. By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), 2023-2028
Table 16. By Application – Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), 2017-2022
Table 20. By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), 2023-2028
Table 21. By Region – Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), 2017-2022
Table 25. By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), 2023-2028
Table 26. By Country - North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, (Kg), 2017-2022
Table 29. By Country - North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, (Kg), 2023-2028
Table 30. By Country - Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, (Kg), 2017-2022
Table 33. By Country - Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, (Kg), 2023-2028
Table 34. By Region - Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, (Kg), 2017-2022
Table 37. By Region - Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, (Kg), 2023-2028
Table 38. By Country - South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, (Kg), 2017-2022
Table 41. By Country - South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, (Kg), 2023-2028
Table 46. Eli Lilly Corporate Summary
Table 47. Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offerings
Table 48. Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 49. Janssen Pharmaceuticals Corporate Summary
Table 50. Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offerings
Table 51. Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 52. Astellas Corporate Summary
Table 53. Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offerings
Table 54. Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 55. Boehringer Ingelheim Corporate Summary
Table 56. Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offerings
Table 57. Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 58. AstraZeneca Corporate Summary
Table 59. AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offerings
Table 60. AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 61. Bristol Myers Squibb Corporate Summary
Table 62. Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offerings
Table 63. Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 64. Kotobuki Pharmaceutical Corporate Summary
Table 65. Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offerings
Table 66. Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 67. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 68. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Capacity Market Share of Key Manufacturers, 2020-2022
Table 69. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production by Region, 2017-2022 (Kg)
Table 70. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production by Region, 2023-2028 (Kg)
Table 71. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Opportunities & Trends in Global Market
Table 72. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Drivers in Global Market
Table 73. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Restraints in Global Market
Table 74. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Raw Materials
Table 75. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Raw Materials Suppliers in Global Market
Table 76. Typical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Downstream
Table 77. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Downstream Clients in Global Market
Table 78. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segment by Type
Figure 2. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segment by Application
Figure 3. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, 2017-2028 (US$, Mn)
Figure 7. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue in 2021
Figure 9. By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share, 2017-2028
Figure 10. By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share, 2017-2028
Figure 11. By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price (USD/Kg), 2017-2028
Figure 12. By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share, 2017-2028
Figure 13. By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share, 2017-2028
Figure 14. By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price (USD/Kg), 2017-2028
Figure 15. By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share, 2017-2028
Figure 16. By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share, 2017-2028
Figure 17. By Country - North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share, 2017-2028
Figure 18. By Country - North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share, 2017-2028
Figure 19. US Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share, 2017-2028
Figure 24. Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 25. France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share, 2017-2028
Figure 33. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 37. India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share, 2017-2028
Figure 39. By Country - South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share, 2017-2028
Figure 40. Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share, 2017-2028
Figure 44. Turkey Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 48. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Region, 2021 VS 2028
Figure 50. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segment by Type
Figure 2. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segment by Application
Figure 3. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, 2017-2028 (US$, Mn)
Figure 7. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue in 2021
Figure 9. By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share, 2017-2028
Figure 10. By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share, 2017-2028
Figure 11. By Type - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price (USD/Kg), 2017-2028
Figure 12. By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share, 2017-2028
Figure 13. By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share, 2017-2028
Figure 14. By Application - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price (USD/Kg), 2017-2028
Figure 15. By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share, 2017-2028
Figure 16. By Region - Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share, 2017-2028
Figure 17. By Country - North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share, 2017-2028
Figure 18. By Country - North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share, 2017-2028
Figure 19. US Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share, 2017-2028
Figure 24. Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 25. France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share, 2017-2028
Figure 33. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 37. India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share, 2017-2028
Figure 39. By Country - South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share, 2017-2028
Figure 40. Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share, 2017-2028
Figure 44. Turkey Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 48. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Region, 2021 VS 2028
Figure 50. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Value Chain
Figure 51. Marketing Channels
